domingo, 16 de febrero de 2025

Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer

https://www.news-medical.net/news/20250214/Scottish-Medicines-Consortium-approves-Libtayo-as-second-line-treatment-for-advanced-cervical-cancer.aspx

No hay comentarios: